Similar Articles
401 Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1
402 Low body mass index is an independent predictor of poor long-term prognosis among patients with resectable gastric cancer
403 Impact of metabolism-related mutations on the heart rate of gastric cancer patients after peritoneal lavage
404 Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis
405 Pancreaticoduodenectomy after neoadjuvant chemotherapy for gastric cancer invading the pancreatic head: A case report
406 Survival outcomes and prognostic indicators for gastric cancer patients with positive peritoneal wash cytology but no peritoneal metastasis after radical gastrectomy
407 Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer
408 Individualized treatment for gastric cancer with rib metastasis: A case report
409 Blockage of ETS homologous factor inhibits the proliferation and invasion of gastric cancer cells through the c-Met pathway
410 Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA